• Explore /
  • Poster
  • / c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naïve prostate cancer that retains RB expression.

c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naïve prostate cancer that retains RB expression.

Abstract Poster

Authors

null

William Kevin Kelly

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA

William Kevin Kelly , James Luke Godwin , Jean H. Hoffman-Censits , Karen E. Knudsen , Renee De Leeuw , Benjamin E. Leiby , Traci Southwell , Christine Hubert , David C. Smith , Gurkamal S. Chatta , Jahan Aghalar , Howard I. Scher , Rohit Bose , Karen A. Autio , Wassim Abida , Susan F. Slovin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02555189

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS384)

DOI

10.1200/JCO.2018.36.6_suppl.TPS384

Abstract #

TPS384

Poster Bd #

P2

Abstract Disclosures

Similar Posters

First Author: Edwina S. Baskin-Bey

First Author: Adam McLain Kase

First Author: Joaquin Mateo

First Author: Paul Vincent Viscuse